Hyperhep B
220 [iU]/mL · Injection
- Prescription only
- Human Immunoglobulin
- Active substance
- Hepatitis B Immune Globulin (human)
- Made by
- GRIFOLS USA, LLC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
This information is not included in the verified source. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Nabi-HB). It describes the substance, not this exact product.
Hepatitis B Immune Globulin (Human) products provide passive immunization for individuals exposed to the hepatitis B virus as evidenced by a reduction in the attack rate of hepatitis B following use 6-9.
Clinical studies 10,11 conducted prior to 1983 with hepatitis B immune globulins similar to Nabi-HB indicate the advantage of simultaneous administration of hepatitis B vaccine and Hepatitis B Immune Globulin (Human).
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-04-10
Safety of the active substance
From the US prescribing label for the same active substance (Nabi-HB). It describes the substance, not this exact product.
- Individuals known to have had an anaphylactic or severe systemic reaction to human globulin should not receive Nabi-HB, Hepatitis B Immune Globulin (Human), or any other human immune globulin.
- Nabi-HB contains not more than 40 micrograms per mL IgA.
- Individuals who are deficient in IgA have the potential to develop antibodies against IgA and anaphylactic reactions.
- The physician must weigh the potential benefit of treatment with Nabi-HB against the potential for hypersensitivity reactions.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Details
| Made by | GRIFOLS USA, LLC |
|---|---|
| Active substance | Hepatitis B Immune Globulin (human) |
| Strength | 220 [iU]/mL |
| Form | Injection |
| Route | Intramuscular |
| Packs | 1 VIAL, GLASS in 1 CARTON / 1 mL in 1 VIAL, GLASS · 1 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS |
| NDC | 13533-636 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.